Canada - Rashin yin amfani da barasa ya fi kowa fiye da yadda masana'antun abin sha za su yi imani da su. A cikin shekarun 50 da 60, an yi nazari kan magungunan tabin hankali irin su LSD da psilocybin da kuma amfani da su (nasara) wajen maganin shaye-shaye, kuma a yau wasu tsirarun kamfanoni a duniyar masu tabin hankali sun tashi daga inda binciken ya tsaya.
Abun da aka fi amfani da shi, abin zagi da cin zarafi a Kanada shine barasa, tare da ɗaya cikin biyar na Kanada waɗanda suka cancanci zama masu shaye-shaye, a cewar Statistics Canada. Duk da yake daidaita amfani da barasa yana nufin za mu iya jin daɗinsa ba tare da irin wannan hukunci ba ko kuma wulakanci da aka yi wa mutanen da ke amfani da kwayoyi kamar tabar heroin ko hodar iblis, haɗarin amfani da barasa ba za a iya wuce gona da iri ba. Yin amfani da barasa na ɗaya daga cikin manyan abubuwan da ke haifar da mutuwar ciwon daji, kuma a cikin ƙasa kamar Kanada, kusan mutane takwas ne ke mutuwa a asibiti a kowace rana sakamakon mutuwar barasa. Matsalolin shan barasa kuma yana kashe mutanen Kanada kuɗi da yawa: kusan dala biliyan 15 a shekara.
Takaitaccen Tarihin Rashin Amfani da Barasa da Binciken LSD
Yana iya zama abin mamaki, amma Kanada ta kasance gida ga wasu daga cikin binciken farko na psychedelic binciken yadda LSD zai iya rinjayar rashin amfani da barasa. Masu bincike na majagaba da masu tabin hankali Humphry Osmond (mutumin da ya kirkiro kalmar 'psychedelics') da Abram Hoffer sun kasance daga cikin na farko da suka fara maganin shaye-shaye tare da LSD a Weyburn, Saskatchewan.
A shekara ta 1959, wasu za su ce LSD shine "magani' don shaye-shaye, har ma da Alcoholics Anonymous wanda ya kafa Bill Wilson zai ba da shawarar cewa ya kamata a haɗa maganin a cikin magani. A cikin New Westminster, BC a wani sanannen asibitin Hollywood, Dr. J Ross MacLean da Al Hubbard kuma suna ba da jiyya na LSD don yanayi daban-daban, gami da shaye-shaye, kuma suna kula da shahararrun mutane kamar Cary Grant da Andy Williams. An yi amfani da maganin har zuwa 1975.
Gudun bincike na biyu akan LSD akan amfani da barasa
Wani bincike-bincike da aka buga a cikin 2012 ya gano cewa a cikin gwaje-gwajen sarrafawa guda shida da aka bazu wanda aka gudanar da kashi ɗaya na LSD, marasa lafiya da aka ba LSD a maimakon placebo sun fi samun ci gaba a lokutan da suka biyo baya. Wani bincike na kan layi wanda Johns Hopkins ya yi na 2019 wanda ba a san shi ba ya tambayi mahalarta game da yadda suke amfani da psychedelic don shawo kan barasa ko rashin amfani da kayan maye. Kafin kwarewarsu, kusan kashi uku cikin huɗu na mahalarta sun cika ka'idodin rashin amfani da barasa. Dangane da ra'ayoyinsu kan binciken, kashi 83 cikin XNUMX sun daina cika ka'idojin rashin amfani da barasa bayan shan LSD, ko da ba su da niyyar canza yadda suke sha.
Bayan binciken farko na bincike, LSD ya bayyana a matsayin psychedelic na zaɓi don rashin amfani da barasa, amma ƙarin binciken da aka yi kwanan nan ya nemi tantance yadda tasirin psilocybin zai iya zama magani. Wani makafi guda biyu, bazuwar, binciken da aka sarrafa na placebo da aka buga a cikin 2018 ya gano cewa bayan makonni 12 na psychotherapy da zaman psilocybin guda biyu, mahalarta sun gauraya amma sakamako mai kyau, tare da wasu ba da barasa gaba ɗaya, yayin da wasu sun sami damar rage yawan amfani da su - har ma. idan ba su da wani. sufi ko kololuwar gogewar hauka.
Kamfanoni uku na jama'a da ke aiki akan rashin amfani da barasa
Kimiyyar Rayuwa ta Awakn (NEO: AWKN) (OTC: AWKNF)
A watan Fabrairu, Awakn Life Sciences ya sanar da sakamakon gwajin asibiti na MDMA ga marasa lafiya da ke da barasa. Amintaccen lakabin buɗaɗɗen, haƙuri da bincike-binciken ra'ayi bai nuna wani sakamako mai illa ba. A cikin makonni takwas na farfadowa, an gudanar da mahalarta MDMA a cikin lokuta guda biyu, tare da ilimin halin dan Adam kafin, lokacin, da kuma bayan kwarewa. Binciken da aka yi na watanni tara ya gano cewa yawancin sun fara sha kadan, tare da matsakaicin adadin abubuwan sha da ake cinyewa a kowane mako ya ragu daga 130,6 zuwa 18,7.
Psilera Bioscience
Psilera ya haɗu tare da ƙungiyar masu bincike daga Jami'ar Florida don nazarin abubuwan da aka mallaka da kuma kwatanta tasirin su zuwa na 4-AcO-DMT ko psiacetin, wani nau'i na psilocybin na roba. Binciken da aka yi daidai zai nemi sanin yadda magungunan su ke shafar rashin amfani da barasa.
Magungunan Clearmind (CSE: CMND)
Clearmind, wanda ke zaune a Vancouver, wani kamfani ne na haɓaka magunguna da ke mayar da hankali kan shaye-shaye da shaye-shaye, tare da ɗan takararsa na neman yin nazarinsa don magani. Ezekiel Golan, a yau mai ba da shawara na musamman na kamfanin kan kirkire-kirkire da sabbin tsare-tsare, ya gano kwayoyin halittar kuma ya fada wa Guardian a cikin 2016 cewa a cikin kananan allurai "yana jin kamar barasa amma ba ya da illa."
MAYU (5-Methoxy-2-aminoindan) sabon kwayoyin halitta ne na psychoactive, wanda ke aiwatar da gogewar euphoric kamar barasa da rage sha'awar cinye abubuwan sha. Kamfanin yana riƙe da haƙƙin mallaka guda shida don amfani da MEAI don magance matsalar Amfani da Barasa da yawan cin abinci. Sakamakon binciken preclinical na MEAI ya nuna babban bayanin martaba na aminci da ingantaccen tasiri, yana ƙara goyan bayan shawarar kamfanin don gudanar da bitar Sabbin Magungunan IND.
Sources ciki har da Leafie (EN), PsychedelicInvest (EN), Rahoton Dales (EN), UNSW (EN)
